38 results on '"Tsibulak, Irina"'
Search Results
2. Global survey on training and practice in sentinel lymph node mapping for endometrial and cervical cancer among early-career gynecologic oncologists
3. Molecular tumor board for gynecologic malignancies: the real-world experience from the Department for Gynecology and Gynecologic Oncology of Kliniken Essen-Mitte
4. Minimally invasive compared to open surgery in patients with low-risk cervical cancer following simple hysterectomy: An exploratory analysis from the Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial
5. Consensus on surgical technique for sentinel lymph node dissection in cervical cancer
6. Global practice patterns of sentinel lymph node biopsy in endometrial cancer: a survey from the European Network of Young Gynecologic Oncologists (ENYGO)
7. Tumor biology and impact on timing of surgery in advanced epithelial ovarian cancer
8. Social media ambassadors and collaboration with OncoAlert: a European Network of Young Gynae Oncologists study of comparative Twitter analysis of #ESGO2021 and #ESGO2022
9. Enhanced recovery after cesarean section (ERAC): Where are we in Austria?
10. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer
11. Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
12. Dubious effects of methadone as an “anticancer” drug on ovarian cancer cell-lines and patient-derived tumor-spheroids
13. The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective
14. Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective
15. Hopes and failures in front-line ovarian cancer therapy
16. #756 Consensus on surgical steps for sentinel lymph node dissection in cervical cancer
17. #657 Global survey on training in sentinel lymph node mapping for endometrial and cervical cancer
18. #644 Surgical management of FIGO stage IV epithelial ovarian cancer versus FIGO stage IIIC: the real-world experience from KEM
19. Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
20. Immunotherapy in ovarian cancer: fake news or the real deal?
21. 2022-RA-1074-ESGO AGO-OVAR 2.29 (ENGOT-ov34): atezolizumab in combination with bevacizumab and chemotherapy vs bevacizumab and chemotherapy in recurrent ovarian cancer
22. Time without symptoms or toxicity (TWiST) in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib or placebo plus bevacizumab: Analysis of PAOLA-1/ENGOT-ov25 phase III trial.
23. The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective
24. The Impact of COVID-19 Pandemic on Gynecological and Breast Cancer Detection Rate: A Tertiary Center Perspective.
25. Abstract 947: Effects of methadone on ovarian cancer cell-lines and patient-derived tumor-spheroids
26. Global practice patterns of sentinel lymph node biopsy in endometrial cancer: a survey from the European Network of Young Gynecologic Oncologists (ENYGO)
27. Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohort
28. Abstract PO-038: Strong decline of newly diagnosed gynecologic and breast cancers during the COVID-19 pandemic: A retrospective analysis from Innsbruck, Austria
29. The miR-34 family and its clinical significance in ovarian cancer
30. Clinical Impact of RANK Signalling in Ovarian Cancer
31. Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer
32. NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer
33. Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohort.
34. BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
35. Clinical impact of BRCA1 and BRCA2 mRNA expression in ovarian cancer.
36. The microRNA 34 family and its clinical significance in ovarian cancer
37. BRCA1/2 mRNA EXPRESSION AS A PROGNOSTIC FACTOR IN OVARIAN CANCER
38. Outcomes of low-volume metastatic disease among patients with early-stage squamous cell carcinoma undergoing sentinel lymph node biopsy: Results from the International Vulvar Cancer Consortium (IVUCCO).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.